Biovail Corporation (NYSE:BVF)(TSE:BVF), Toronto, has announced that its 30mg dosage strength of generic Procardia XL (once daily nifedipine) has been granted final approval by the Food and Drug Administration (FDA) for immediate marketing in the United States.
What does FA stand for?
FA stands for Final Approval
This definition appears very frequently and is found in the following Acronym Finder categories:
- Military and Government
See other definitions of FA
We have 56 other meanings of FA in our Acronym Attic
- Field Artillery
- Field Assistance
- Field Authorization
- Fiery Avenger (Everquest game)
- Fighter Allocator
- Fijian Association (political party)
- Filiae Amatissimae (Latin: To (My) Beloved Daughter, epigraphy)
- Final Acceptance
- Final Alert (mapmaking program)
- Final Approach
- Final Art (desktop publishing/printing/design; approved by client and ready to go to production)
- Final Assembly
- Finally Approved (sarcastic variation of Final Approval)
- Finance Academy under the Government of the Russian Federation
- Finance and Accounting
- Financial Advisor
- Financial Agent
- Financial Aid
- Financial Assurance
- Finanzamt (German: revenue office)
Samples in periodicals archive:
Final approval for advanced exploration expected in November Davidson Tisdale Ltd.
If the new regulations receive final approval from the council, they would apply in the April 1997 elections for the City Council, the school board, the city clerk and the city treasurer.
Final approval is expected upon expiry of patent protection for the brand product on December 29, 2007.
The closing is subject to the final approval of the FTC and the EC, and details of the transaction will be disclosed after final approval.
Final approval is expected upon the earlier of a favorable decision in the case or expiry of the mandatory stay of approval in August 2007.
Food and Drug Administration (FDA) to refrain from issuing a final approval for Teva's Abbreviated New Drug Application (ANDA) for generic pravastatin 10, 20 and 40 mg strengths until after 5:00 pm on Friday, April 21, 2006, in order to give Apotex an opportunity to appeal today's ruling in favor of Teva.
Final approval is anticipated upon expiry of patent protection in September 2008.